PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus erythematosus, systemic |
| Symptom | C0020538|hypertension |
| Sentences | 23 |
| PubMedID- 26087631 | Specific features of hypertension in patients with systemic lupus erythematosus. |
| PubMedID- 22084605 | Asymptomatic pulmonary hypertension in systemic lupus erythematosus. |
| PubMedID- 20012052 | Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome. |
| PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
| PubMedID- 25929760 | Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. |
| PubMedID- 26401258 | All patients with pulmonary hypertension and a diagnosis of systemic sclerosis, systemic lupus erythematosus, or mixed connective tissue disease who underwent the 6mwt between august 1, 2009, and october 30, 2011, were included (n = 66). |
| PubMedID- 23104392 | Intracranial hypertension associated with systemic lupus erythematosus in a young male patient. |
| PubMedID- 22983159 | To develop a more comprehensive understanding of the clinical and pathological characteristics of pulmonary hypertension associated with systemic lupus erythematosus (ph/sle) in the chinese population, a systematic review of the literature up to 2012 was conducted. |
| PubMedID- 26084696 | An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus. |
| PubMedID- 24134304 | Objectives: to determine whether disease activity verified by laboratorial parameters is associated with a higher frequency of hypertension in patients with systemic lupus erythematosus (sle) without renal impairment and to investigate factors that could influence this hypertension. |
| PubMedID- 24755203 | Arterial stiffness, antiphospholipid antibodies, and pulmonary arterial hypertension in systemic lupus erythematosus. |
| PubMedID- 25750566 | Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival. |
| PubMedID- 22489252 | Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction. |
| PubMedID- 24238697 | Pulmonary hypertension in systemic lupus erythematosus. |
| PubMedID- 22841984 | Objectives: to investigate the prevalence and predictors of pulmonary hypertension (ph) in patients with systemic lupus erythematosus (sle) and to validate a diagnostic strategy. |
| PubMedID- 23560122 | There were also other conditions such as small kidney, tuberculosis infection, urinary tract obstruction, history of schistosomiasis infection, systemic lupus erythematosus (sle) with hypertension, malaria infection, malignancy with hypertension and traditional african herbal poisoning which were found in the patients. |
| PubMedID- 24633036 | Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus. |
| PubMedID- 23634923 | Results: the patients' median age was 43 years (range 30-55 years) and the ich etiology was hypertension in 4 of 5 patients, and systemic lupus erythematosus vasculitis in 1 patient. |
| PubMedID- 22300830 | Objective: to evaluate the occurrence of idiopathic intracranial hypertension (iih) in patients with systemic lupus erythematosus (sle) and to describe the manifestations, treatments and outcomes in these patients. |
| PubMedID- 24562636 | Disease activity is related to acute response to vasodilator in pulmonary artery hypertension associated with systemic lupus erythematosus. |
| PubMedID- 24263143 | Pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause. |
| PubMedID- 24599923 | Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival. |
| PubMedID- 21376432 | Pulmonary arterial hypertension in systemic lupus erythematosus. |
Page: 1